Treatable causes of sudden death: Not really "treatable" or not really the cause?

Journal of the American College of Cardiology

Volumn 38, Issue 6, 2001, Pages 1725-1727

  Viskin, Sami ^a,c   Halkin, Amir ^a   Olgin, Jeffrey E ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b INDIANA UNIVERSITY   (United States)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HYPOKALEMIA; MORTALITY; NOTE; PRIORITY JOURNAL; PROGNOSIS; SUDDEN DEATH; TORSADE DES POINTES;

EID: 0035890310     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01588-1     Document Type: Editorial

References (19)

1. ACC/AHA Guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
2. Life threatening ventricular arrhythmias due to transient or correctable causes - High risk for death in follow-up
3. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias
4. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction
5. Recurrent ventricular fibrillation and modes of death in survivors of out-of-hospital ventricular fibrillation
6. Characteristics of the resuscitated out-of-hospital cardiac arrest victim with coronary heart disease
7. Autonomic mechanisms and sudden death: New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction
8. Cisapride and torsades de pointes in a pacemaker patient
9. A common polymorphism associated with antibiotic-induced cardiac arrhythmia
10. Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter
11. Conduction disturbance and ST-elevation following cardioversion
12. Reversible myocardial depression in survivors of cardiac arrest
13. The long QT syndromes and torsade de pointes
14. Postresuscitation electrolyte changes: Role of arrhythmia and resuscitation efforts in their genesis
15. Management of survivors of cardiac arrest: Is electrophysiologic testing obsolete in the era of implantable defibrillators?
16. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias
17. Identification of patients most likely to benefit from ICD therapy: The Canadian Implantable Defibrillator Study
18. Coronary artery revascularization in patients with sustained ventricular arrhythmias in the chronic phase of a myocardial infarction: Effects on the electrophysiologic substrate and outcome
19. Ventricular fibrillation and polymorphic ventricular tachycardia with critical coronary artery stenosis: Does bypass surgery suffice?